GlassScriptPhysician profile
Abe G Osbourne
NPI 1407941743
$1,370.74
in general payments reported to CMS, 2019-2025
18 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $69.60 · 2022: $419 · 2023: $214 · 2024: $309 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $432.40 | 2023-2025 | Qutenza |
| Grt US Holding, INC. | $262.83 | 2021-2022 | |
| Orthofix Medical, INC. | $166.18 | 2022-2025 | Physio-Stim |
| Medtronic, INC. | $105.73 | 2022 | |
| Convatec INC. | $49.88 | 2021 | |
| Paragon 28, INC. | $48.43 | 2023-2024 | Mtp, Additive Orthopedics |
| Horizon Therapeutics Plc | $48.27 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $44.65 | 2025 | |
| Polynovo North America LLC | $24.61 | 2025 | Novosorb Btm |
| Melinta Therapeutics, LLC | $23.76 | 2023 | Kimyrsa |
| Ani Pharmaceuticals, INC. | $23.61 | 2024 | Purified Cortrophin Gel |
| Smith+Nephew, INC. | $23.51 | 2023 | Collagenase Santyl |
| Amgen INC. | $22.59 | 2024 | Krystexxa |
| Reprise Biomedical, INC. | $22.32 | 2024 | Miro3d |
| Organogenesis INC. | $22.00 | 2025 | Puraply Wound Matrix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $21.66 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Nevro Corp. | $14.25 | 2023 | Senza |
| Bioventus LLC | $14.06 | 2023 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abe Osbourne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.